A · Agilent Technologies, Inc.
$153.84
-3.85 (-2.44%)
At close · Aug 28
Market Cap
$43.45B
Shares
282.43M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$153.84
Open$156.02
Day$152.77–156.10
52W close$110.24–159.00
Avg vol 30d2.1M
Short int5.2M · 1.8% float · 3.8d
Short vol46%
Last earningsAug 26, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jun 1
Up next
Next earnings call
Nov 25, 2026
Est · unconfirmed
· in 13 wks
FQ4-26 quarter ends
~Oct 31, 2026
Est
filed Jun 1, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+17%
above
Price vs 50-day avg
+10%
above
RSI (14)
61
neutral
MACD trend
Positive
52-week position
89%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+11%
trailing
6-month return
+32%
trailing
YTD return
+13%
this year
Relative strength
+18%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $140 › 200d $132 — 50d above 200d
Institutional flow
Accumulating
+4% holders QoQ · +144 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.83% of float · ▼ -10.1% MoM · 3.8 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
1,120 holders — near 3-yr high, broad support
Squeeze score
48
elevated · 0–100
Fundamentals
Revenue growth
+6%
Y/Y
EPS growth
+3%
Y/Y
Free cash flow
$1.2B
Valuation
P/E 30.9
below peers
Buyback
$1.7B
remaining
Balance sheet
$1.6B
net debt
Quant / Vol
risk profile
Volatility
33%
annualized · 1-yr
Max drawdown
−30%
past year
ATR
2.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 26, 2026
Fiscal year 2026
Fiscal year 2026 revenue
Raised
$7.49B – $7.51B
May 27, 2026
$7.39B – $7.49B
changed to
Aug 26, 2026
$7.49B – $7.51B
prior FY $6.95B
midpoint +7.9% Y/Y
Non-GAAP fiscal year 2026 EPS
Non-GAAP
Initiated
$6.18 – $6.21
Fourth-quarter 2026
Fourth-quarter 2026 revenue
$1.98B – $2B
prior qtr $1.84B
midpoint +8.4% QoQ
Prior guidance
period ended
· from the 8-K filed May 27, 2026
Non-GAAP EPS
· third quarter 2026
$1.48 – $1.50
Fiscal third-quarter 2026 revenue
· fiscal third-quarter 2026
$1.83B – $1.85B
Guided vs delivered
· last 8 settled
Revenue
Fiscal first-quarter 2026
guided $1.79B – $1.82B
$1.8B
In line
Q4 revenue outlook
fourth quarter of fiscal year 2025
guided $1.82B – $1.84B
$1.86B
Beat +1.6%
Revenue
Q3
guided $1.65B – $1.68B
$1.74B
Beat +4.7%
Full-year revenue outlook
Full Year 2025
guided $6.68B – $6.76B
$6.95B
Beat +3.4%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+17%
Bullish
Price vs 50-day avg
+10%
Bullish
RSI (14)
61
Neutral
MACD trend
Positive
Bullish
52-week position
89%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $140 › 200d $132 — 50d above 200d
Institutional flow
Accumulating
+4% holders QoQ · +144 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.83% of float · ▼ -10.1% MoM · 3.8 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
1,120 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $110
Now $154 · 89%
Range high $159
vs 200-day avg +17%
vs 50-day avg +10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| ACG operating margin | 34.3% | Q3 FY2026 | — |
|
|
|||
| AMG operating margin | 24.9% | Q3 FY2026 | — |
|
|
|||
| core (organic constant currency) revenue growth non-GAAP | 7% | Q3'26 | — |
|
|
|||
| LDG operating margin | 23.5% | Q3 FY2026 | — |
|
|
|||
| Non-GAAP diluted EPS non-GAAP | $4.48 | Nine Months Ended July 31, 2026 | — |
|
|
|||
| Non-GAAP income from operations non-GAAP | $532M | Q3'26 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP GAAP Income from operations 444M
+15M Restructuring and other related costs
+21M Intangible amortization
+37M Transformational initiatives
+7M Acquisition and integration costs
+8M Other
= Non-GAAP income from operations 532M
|
|||
| Non-GAAP net income non-GAAP | $1.27B | Nine Months Ended July 31, 2026 | — |
|
|
|||
| Non-GAAP operating margin non-GAAP | 28.3% | Q3 FY2026 | — |
|
|
|||
| Non-GAAP operating margin sequential expansion non-GAAP | 190 | Q3 FY2026 | — |
|
|
|||
| Non-GAAP operating margin year-over-year expansion non-GAAP | 130 | Q2 FY2026 | — |
| core revenue growth non-GAAP | 4.4% | first quarter ended January 31, 2026 | — |
| Non-GAAP effective tax rate non-GAAP | 14.5% | Three Months Ended January 31, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
A
this stock
Agilent Technologies, Inc.
|
$43.45B | +13.1% | +6.4% | 30.9 | 1.8% |
|
TMO
Thermo Fisher Scientific Inc.
|
$230.05B | +7.4% | +14.5% | 33.5 | 1.3% |
|
DHR
Danaher Corp /De/
|
$151.51B | -5.6% | +8.5% | 38.2 | 1.2% |
|
NTRA
Natera, Inc.
|
$48.82B | +42.4% | -2.8% | — | 3.0% |
|
IQV
Iqvia Holdings Inc.
|
$43.79B | +16.1% | +41.6% | 32.6 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| A | -3.3% | +11.2% | +31.9% | +11.2% | +13.1% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -3.7% | +8.2% | +18.5% | +8.2% | +0.2% |
Capital returns
Latest dividend
$0.255
/ share · ex Jun 30, 2026
Paid (TTM)
$1.013
/ share · 4 payouts
Dividend yield (TTM, derived)
0.66%
Buyback program
· as of Apr 30, 2026
Authorized
$2.00B
Spent (derived)
$268.00M
Remaining
$1.73B
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1090872
CUSIP
00846U101
13F (30d)
802 filings
756 filers
Visit website
Investor relations